Trials & R&D · first seen 8h ago, updated 8h ago
Sarepta to pay Regenxbio $39M to settle gene therapy claims; Vida eyes fourth fund
Plus news about Frazier Life Sciences, BigHat Biosciences, Kasvu Therapeutics, Arcturus Therapeutics, Oruka Therapeutics and Viking Therapeutics. Sarepta Therapeutics settles gene therapy suit: Sarepta has agreed to pay Regenxbio $39 millio…
Summary from Endpoints News.